Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-10T10:01:20.047Z Has data issue: false hasContentIssue false
  • English
  • Français

The naloxone conjunctival test: an underused tool? A review of the available data

Published online by Cambridge University Press:  16 April 2020

M Auriacombe ,
JW Cornish ,
L Skoble  and
CP O’Brien
M Auriacombe*
Affiliation:
Addiction Treatment Research Center, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, Pennsylvania19104, USA Groupe d'Etude des Toxicomanies, Laboratoire de Psychiatrie, Université de Bordeaux II, Centre Carriere, 121 rue de la Béchade, 33076Bordeaux cedex, France
JW Cornish
Affiliation:
Addiction Treatment Research Center, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, Pennsylvania19104, USA Groupe d'Etude des Toxicomanies, Laboratoire de Psychiatrie, Université de Bordeaux II, Centre Carriere, 121 rue de la Béchade, 33076Bordeaux cedex, France
L Skoble
Affiliation:
Addiction Treatment Research Center, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, Pennsylvania19104, USA
CP O’Brien
Affiliation:
Addiction Treatment Research Center, University of Pennsylvania, 3900 Chestnut Street, Philadelphia, Pennsylvania19104, USA
*
*Correspondence and reprints to Bordeaux address.
Get access

Summary

There is currently no simple and morbidity-free procedure available to determine opiate dependence in patients. There is preliminary evidence, however, that the naloxone conjunctival test may be useful in this regard. This test consists of instilling a drop of saline solution of naloxone hydrochloride (an opiate-receptor antagonist) into the subject's eye. This causes significant homolateral mydriasis (anisocoria) in the eye of a chronic opioid-dependent subject and not in that of a non-dependent subject. We reviewed the international literature on the naloxone conjunctival test using the Medline database and a manual search of major scientific journals specialized in the field of substance abuse. Up to March 1995, we identified six articles dealing specifically with the use of opiate antagonist ophthalmic solutions in populations of chronic opioid addicts. Four of the articles reported the occurrence of mydriasis when a solution of naloxone is used in opioid addicts. Two of the articles reported that there was no differential change in pupil size when the naloxone solution is used; however, one study used a much weaker and the other a much stronger solution of naloxone than reported in the other studies. From our review of the literature, it appears that the naloxone conjunctival test holds great promise as a simple and morbidity-free method of testing for chronic opioid addiction and, therefore, it should be studied further and its usage eventually developed.

Keywords

opioid dependenceaddictiondiagnosisopiatesnaloxonenaloxone conjunctival test
Type
Original articles
Information
European Psychiatry , Volume 12 , Issue 5 , 1997 , pp. 255 - 258
Copyright
Copyright © European Psychiatric Association 1997

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

1

Portions of this paper were presented at the 55th Annual Scientific Meeting of the College on Problems of Drug Dependence, Toronto, Canada, June 1993.

References

Bareta, JC, Larson, DB, Lyons, JS, Zorc, JJ. A comparison of manual and MEDLARS reviews of the literature on consultation-liaison psychiatry. Am J Psychiatry 1990; 147: 1040–1042Google ScholarPubMed
Bellini, C, Boccuni, M, D’Egidio, P, Fanciullaci, M, et al.. Naloxone anisocoria: a non invasive, inexpensive test for opiate addiction. Int J Clin Pharmacol Res 1982; 2: 55–60Google Scholar
Creighton, FJ, Ghodse, AH. Naloxone applied to conjunctiva as a test for physical opiate dependence. Lancet 1989; 8641: 748–750CrossRefGoogle Scholar
Fanciullacci, M, Boccuni, M, Pietrini, U, Sicuteri, F. The naloxone conjunctival test in morphine addiction. Eur J Pharmacol 1980; 61: 319–32010.1016/0014-2999(80)90136-3CrossRefGoogle ScholarPubMed
Fanciullacci, M, Boccuni, M, Pietrini, U, Sicuteri, F. Search for opiate receptors in the human pupil. Int J Clin Pharmacol Res 1981; 1: 139–143Google Scholar
Ghodse, All, Bewley, TH, Kearney, MK, Smith, SE. Mydriatic response to topical naloxone in opiate abusers. Br J Psychiatry 1986; 148: 44–4610.1192/bjp.148.1.44CrossRefGoogle ScholarPubMed
Loimer, N, Grunberger, J, Linzmayer, L, Schmid, R. Conjunctival naloxone is no decision aid in opioid addiction. Lancet 1990; 335: 1107–1108CrossRefGoogle ScholarPubMed
Murray, KB, Adler, MW, Korczyn, AD. The pupillary effects of opioids. Life Sci 1983; 33: 495–50910.1016/0024-3205(83)90123-6CrossRefGoogle ScholarPubMed
Sanchez-Ramos, JR, Senay, EC. Ophthalmic naloxone elicits abstinence in opioid-dependent subjects. Br J Addict 1987; 82: 313–31510.1111/j.1360-0443.1987.tb01485.xCrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.